ESR1 and cancer: Despite the low prevalence of VCAN-undetectable tumors within the ER+ cohort, there was a trend toward more CD8+ T cells within the epithelial compartment of VCAN-undetectable cancers compared to VCAN-detectable tumors (p = 0.065; Supplementary Figure S2).